In Vitro Study of Octacalcium Phosphate Behavior in Different Model Solutions

Area of Science:

• Biomaterials Science
• Materials Chemistry
• Biomineralization

Background:

• Octacalcium phosphate (OCP) is a next-generation bone substitute material and a precursor to biological bone apatite.
• OCP's layered structure facilitates ion-exchange reactions, leading to hydrolysis into hydroxyapatite and ion adsorption.
• The surrounding solution composition critically influences OCP's hydrolysis, surface reactivity, and in vitro/in vivo performance.

Purpose of the Study:

• To investigate the structural alterations of OCP-based materials when exposed to common in vitro model solutions.
• To compare the effects of simulated body fluid (SBF), Dulbecco's phosphate-buffered saline (DPBS), supersaturated calcification solution (SCS), normal saline (NS), and Dulbecco's modified Eagle's medium (DMEM) on OCP.

Main Methods:

• Soaking OCP granules in various model solutions (pH 7.2-7.4).
• Utilizing X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), inductively coupled plasma atomic emission spectrometry (ICP-AES), and scanning electron microscopy (SEM) for structural analysis.
• Assessing osteosarcoma cell cultivation on OCP pre-treated in DMEM.

Main Results:

• Normal saline (NS) caused significant degradation of the OCP structure.
• Dulbecco's phosphate-buffered saline (DPBS) induced minor initial changes, followed by crystal thinning and hydrolysis.
• Simulated body fluid (SBF) and supersaturated calcification solution (SCS) led to precipitate formation and OCP hydrolysis, with SCS showing a greater precipitation effect.
• Dulbecco's modified Eagle's medium (DMEM) pre-treatment enhanced OCP's cytocompatibility.

Conclusions:

• The choice of solution in in vitro procedures significantly impacts OCP's structural integrity and properties.
• Careful selection of contact solutions is crucial to prevent unintended material alterations and ensure reliable experimental outcomes.
• DMEM shows promise for enhancing OCP's biological performance in vitro.